Gregory Lovins
Analyst · Scott Gaffner with Barclays Capital. Please proceed
Thanks, Mitch. Appreciate that. And hello, everybody. As Mitch mentioned, we’re off to a good start to the year. We grew sales by 7% excluding currency and 4% on an organic basis. And we delivered an 18% increase in adjusted earnings per share, driven by strong operating performance and a lower tax rate. Currency translation reduced reported sales by about 1% in the first quarter, with an approximately $0.03 negative impact to EPS. Our adjusted operating margin in the first quarter improved 40 basis points to 10.1%. This was driven primarily by the margin expansion in RBIS. Productivity continues to be a key driver of the year-on-year margin improvement, including about $11 million of incremental savings from restructuring actions net of transition costs. Our adjusted tax rate was 30% in the quarter, reflecting our revised outlook for the full year rate, which is lower than prior year, due largely to geographic and income mix and the adoption of new accounting standards that impact the accounting for taxes on share-based compensation. We now expect the impact of this accounting change to be approximately $0.14 for the year, roughly $0.07 higher than previously anticipated due to the rise in our share price during the quarter. Free cash flow was negative $22 million, which is $15 million better than Q1 of last year. Higher net income and improved operating working capital performance was partially offset by higher capital spend to support our growth strategy. We continue to expect free cash flow conversion for the year of approximately 100% of GAAP net income. We also repurchased approximately 500,000 shares in the quarter at an aggregate cost of $35 million and paid $36 million in dividends. Including dilution, the company’s share count increased by roughly 600,000 shares in the quarter, half of which relates to the tax accounting change. Additionally, you may recall that dilution always has the biggest impact in the first quarter of our year. Overall, our balance sheet remains strong and we have ample capacity to invest in the business, as well as continue returning cash to shareholders in a disciplined manner. As you know, in March, we issued €500 million of 1.25% senior notes, which are due in 2025. We used approximately €200 million of the proceeds to repay short-term borrowings associated with last year's acquisition of Mactac. The remainder will be used primarily to support further investment in the business, including acquisitions. We’re pleased with the results of this first euro offering, which is consistent with our large and growing footprint in Europe and provides us a natural hedge for our balance sheet. On the acquisition front, we closed the previously announced Hanita Coatings deal in March and the integration of that business is underway. The announced acquisition of Yongle Tape is on track to close in the middle of this year as well. Both of these acquisitions will accelerate our ability to grow faster in higher-value categories. We expect the impact to 2017 EPS to be immaterial for each of these transactions as we move through their integration phases. Now, let me turn to the segment results for the quarter. Our Label and Graphic Materials sales were up 9% excluding currency and up approximately 5% on an organic basis. The solid organic growth continues to be led by the emerging markets and Western Europe. The strength in emerging markets continues to be broad-based, with double-digit demand growth in the quarter. We also had a modest benefit from pre-buy activity in China, ahead of our price increase that took effect in late March. Within the mature markets, we continued mid-single digit growth in Western Europe and that was partially offset by some softness in North America, as Mitch indicated. Our high-value categories were up mid-single digits on an organic basis, with low single-digit growth in the combined graphics and reflective businesses, offset by some continued strength in specialty labels. The slower growth in graphics was due mostly to timing of customer purchases as well as a challenging comparison in North America, where the category grew at a mid-teens rate in Q1 of 2016. LGM's operating margin of 12.7% was unchanged from last year as the benefit from higher volume and productivity was offset by unfavorable product mix and higher employee-related costs. The year-over-year impact of price and raw material costs was negligible in the quarter, but we did see some modest sequential raw material inflation and we expect that trend to continue into the second quarter. As I mentioned, we have raised prices in China. And if current inflationary pressures in other markets persist, we will look to raise prices again where appropriate. Shifting now to Retail Branding and Information Solutions, RBIS continues to show good progress from our business transformation, with organic growth of 3% despite a lower contribution from RFID than we have seen in recent quarters. And we had continued meaningful improvement in our operating margin. In the base apparel categories, we continue to see volume growth outpace apparel unit imports in what remains a challenging environment. In addition, the impact of strategic price reductions to improve our competitiveness moderated in the first quarter. As Mitch mentioned, the RFID was up mid-single digits for the quarter, in line with our expectations. We continue to expect this business to deliver 20%-plus growth per year, with volatility in the growth rate from period to period. RBIS’ operating margin improvement reflected the benefits of productivity initiatives and higher volumes, which are partially offset by higher employee-related costs. As the team continues to execute its business transformation, we anticipate continued margin expansion over the balance of the year. In our Industrial and Healthcare Materials segment, our sales also came in better than anticipated, with growth of 4% excluding currency and an organic decline of approximately 1%. Mid-single digit organic growth in industrial categories largely offset the expected decline in healthcare. Operating margin declined in this segment overall due to the sales decline in healthcare categories as well. Let me now turn to our outlook for the balance of the year. We have raised the midpoint of guidance for adjusted earnings per share by $0.18 to an updated range of $4.50 to $4.65. Roughly $0.07 of this increase reflects the stronger operating outlook and another $0.07 comes from the higher-than-expected impact from the tax accounting change. The remainder reflects the reduced headwind from currency translation, which is partially offset by modestly higher share count. We now also expect the impact of restructuring charges and other one-time items to be approximately $0.30 for the full year, a $0.10 increase versus our previous assumption. This reflects the shift in timing of certain charges associated with our restructuring actions and the inclusion of transaction costs from the Yongle Tape acquisition, which was not previously in our guidance. We outline some of the key contributing factors to our EPS guidance on slide nine of the supplemental materials. I’ll focus on the factors that have changed from our previous outlook. We now expect organic sales growth of 3.5% to 4.5% for the full year, reflecting our solid results in the first quarter. At recent foreign exchange rates, we estimate that currency translation will reduce net sales by approximately 1% and reduce pretax earnings by roughly $10 million. As discussed, we’re also expecting interest rate of approximately 30% for the full year. And we expect average shares outstanding, assuming dilution, of 89 million to 89.5 million shares. Our other key assumptions essentially remain unchanged from what we shared last quarter. So, overall, to wrap up, we’re very pleased with the start to the year and our continued progress against our long-term strategic and financial objectives. So, thank you and now we’ll open up the call for your questions.